Recent Finacing
Recent Raise
Orion Biotechnology is a clinical-stage biotech developing precision engineered GPCR-targeted therapeutics, led by its chemokine analog OB-002.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Orion Biotechnology.